Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maralixibat in Infants With Cholestatic Liver Diseases
NCT04729751Phase 2Completed
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Start
- Sep 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of maralixibat in progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome (ALGS), sponsored by Mirum Pharmaceuticals, Inc.. Started Sep 2021; status: completed.
02
Drugs
maralixibat
03
Conditions
progressive familial intrahepatic cholestasis (PFIC)Alagille syndrome (ALGS)
Beyond the preview
Go deeper on NCT04729751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04729751.